Southwestern Medical
Solutions...(SWNM)
SWNM
Enhances Labguard(TM) Diagnostic Device Capabilities...(SWNM)
Announces that, through is
working relationship with medical company Instant Diagnostics, Inc., the
Labguard(TM) diagnostic device will now include a much wider array of diagnostic
testing capabilities.
Full
Press Release...
SWNM Investment Highlights
- Announced that, with the
ongoing success of the patented Labguard(TM) systems in current clinical
trials, the process of manufacturing the product as an OEM licensed medical
product for two major U.S. medical suppliers has begun. The official
licensed OEM version of the Labguard(TM) will be packaged as a unit to be
marketed and sold under each distribution company's label.
- Announced that building of the
prototypes for its Stage 2 proprietary Labguard(TM) health screening system
have been completed ahead of schedule. Clinical testing through the
company's network of assigned independent medical testing laboratories is to
commence immediately.
- Announced that it intends to
introduce a version of the Labguard(TM) system to facilitate a simple urine
test that could be used as an easy cross-check to the traditional PSA
(prostate-specific antigen) test to increase the accuracy of prostate
screening.
- Announced that it has
commenced studies to appraise the potential of several of its in-house
designs to achieve medical-device advancements to the percutaneous
endoscopic gastrostomy (PEG) tube, commonly referred to as the feeding tube.
- Announced that it has plans to
introduce a non-invasive, one-step early menopause detection device in its
Labguard(TM) on-site and at-home Collection & Diagnostic Testing product
lineup.
Overview
Southwestern
Medical Solutions (SWNM) is a development-stage company targeted at the
multibillion-dollar medical devices business. Through internal Research &
Development, as well as the acquisition of proprietary technology developed by
others, Southwestern intends to provide the healthcare industry with significant
advancements in medical supplies and equipment. These technological advancements
will focus upon fulfilling the needs for higher safety, better ease-of-use, and
much-needed economic efficiencies within the healthcare industry.
The
Company's proprietary Labguard(TM) on-site collection & diagnostic testing
technology represents a revolutionary approach that ensures greater safety and
convenience for diagnostic testing administrators at an attractive,
market-competitive price. Currently in the clinical testing/prototype stage,
Labguard has attracted expressions of strong interest from several major
medical-device distribution companies, both in the U.S. and abroad. Numerous
applications of the Labguard to address specific market needs, such as
non-invasive HIV testing, are currently in the design, prototype and/or testing
stages. Southwestern Medical is also involved in prototype design and testing of
the promising Protect-A-Pal(TM) needle safety device, to which it now owns the
world marketing rights.
Approximate
Shares Outstanding: 328M
Market
Cap: $47.6M
Recent
Price: $0.145
For the Full Profile on SWNM please visit http://www.smallcapreview.com/swnm.htm
Initial
Product Launch
Southwestern recently announced
that it had acquired the worldwide rights to the LabGuard Accucheck Collection
System, a technologically advanced device that is expected to significantly ease
the task of on-site collection and testing, thus providing the highest level of
safety and quickest possible results for the large and growing on-site
diagnostic testing/screening market.
- The LabGuard Accucheck?„? will
offer the healthcare community many benefits including:
- Simultaneous detection of
multiple drugs in under 5 minutes
- Integrated collection and
testing device for every sample
- Sterile sample and
reagent/fluid-free handling
- Room temperature storage
- Clear positive/negative
results
- Non-Leak-Spill-proof container
Recent News and Press
Releases
SWNM
Enhances Labguard(TM) Diagnostic Device Capabilities
SWNM
Commences OEM Licensing for Manufacture of Labguard(TM)
Southwestern
Medical Solutions, Inc. Appoints Katherine Helm, R.N. to Newly Established
Medical Advisory Board
Stage
2 Labguard(TM) Prototypes Completed; Clinical Testing to Commence Immediately
Southwestern
Medical's Labguard(TM) Test to Improve Accuracy of Prostate Screening
Feeding
Tube Advancement Studied by Southwestern Medical Solutions
Medical
Devices Diagnostic Testing Company to Support Southwestern Medical Solutions,
Inc. Clinical Testing of Labguard(TM)
Southwestern
Medical to Incorporate Early Menopause Detection in Its Labguard(TM) Product
Line-Up
Southwestern
Medical Expands Its Initial Diagnostic Testing Target Markets for Labguard(TM)
Disclaimer
SmallCapReview.com
feature stock reports are intended to be stock ideas, NOT recommendations.
Please do your own research before investing. It is crucial that you at least
look at current SEC filings and read the latest press releases. For
continuing coverage of SWNM, please sign up for our free newsletter,
SmallCapReview.com
News. Information contained in this report was extracted from current documents
filed with the SEC, the company web site and other publicly available sources
deemed reliable. For more information see our disclaimer section, a link of
which can be found on our web site. This document contains forward-looking
statements, particularly as related to the business plans of the Company, within
the meaning of Section 27A of the Securities Act of 1933 and Sections 21E of the
Securities Exchange Act of 1934, and are subject to the safe harbor created by
these sections. Actual results may differ materially from the Company's
expectations and estimates. This is an advertisement for Southwestern Medical
Solutions. The purpose of this advertisement, like any advertising, is to
provide coverage and awareness for the company. The information provided in this
advertisement is not intended for distribution to, or use by, any person or
entity in any jurisdiction or country where such distribution or use would be
contrary to law or regulation or which would subject us to any registration
requirement within such jurisdiction or country.
Copyright
SmallCapReview.com. All rights reserved. SmallCapReview.com is not a Registered
Broker/Dealer or Financial Advisor, nor do we hold ourselves out to be. All
materials presented on our web site and individual reports released to the
public through this web site, e-mail or any other means of transmission are not
to be regarded as investment advice and are only for informative purposes.
Before making a purchase or sale of any securities featured on our web site
or mentioned in our reports, we strongly encourage and recommend consultation
with a registered securities representative. This is not to be construed as
a solicitation or recommendation to buy or sell securities. As with any stock,
companies we select to profile involve a degree of investment risk and
volatility. Particularly Small-Caps and OTC-BB stocks. All investors are
cautioned that they may lose all or a portion of their investment if they decide
to make a purchase in any of our profiled companies. Past performance of our
profiled stocks is not indicative of future results. The accuracy or
completeness of the information on our website or within our reports is only as
reliable as the sources they were obtained from. The profile and opinions
expressed herein are expressed as of the date the profile is posted on site and are
subject to change without notice. No investor should assume that reliance on the
views, opinions or recommendations contained herein will produce profitable
results. SmallCapReview.com may hold positions in securities mentioned herein,
and may make purchases or sales in such securities featured on our web site or
within our reports. In order to be in full compliance with the Securities Act
of 1933, Section 17(b), SmallCapReview.com will disclose in it's
disclaimer, what, if any compensation was received for our efforts in
researching, presenting and disseminating this information to our subscriber
database and featuring the report on the SmallCapReview.com website.
SmallCapReview.com has been compensated nine thousand dollars by a third party
for its efforts in presenting the Southwestern Medical profile on its website
and distributing it to its database of subscribers. SmallCapReview.com may
decide to purchase or sell shares on a voluntary basis in the open market
before, during or after the profiling period of this report. Information
presented on our website and within our reports contain "forward looking
statements" within the meaning of Section 27A of
the Securities Act of 1933 and Section 21E of the Securities Exchange Act of
1934. Any statements that express or involve discussions with respect to
predictions, expectations, beliefs, plans, projections, objectives, goals,
assumptions or future events or performance are not statements of historical
fact and may be "forward looking statements." Forward looking
statements are based on expectations, estimates and projections at the time the
statements are made that involve a number of risks and uncertainties which could
cause actual results or events to differ materially from those presently
anticipated. Forward looking statements in this action may be identified through
the use of words such as ???expects??™???, ???will,??? ???anticipates,???
???estimates, ???believes,??? or that by statements indicating certain actions
???may,??? ???could,??? or ???might??? occur.
THE
READER SHOULD VERIFY ALL CLAIMS AND DO THEIR OWN DUE DILIGENCE BEFORE INVESTING IN
ANY SECURITIES MENTIONED. INVESTING IN SMALL CAP SECURITIES IS SPECULATIVE AND
CARRIES A HIGH DEGREE OF RISK.
We
encourage our readers to invest carefully and read the investor information
available at the websites of the Securities and Exchange Commission (SEC) at: http://www.sec.gov
and/or the National Association of Securities Dealers (NASD) at: http://www.nasd.com
. Readers can review all public filings by companies at the SEC's EDGAR
page. The NASD has published information on how to invest carefully at its
website.
|
